Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: Incidence and prognostic significance Journal Article


Authors: Zamarin, D.; Devlin, S. M.; Arcila, M. E.; Landau, H.; Lesokhin, A.; Lendvai, N.; Chung, D. J.; Chimento, D.; Weltz, J.; Babu, D.; Giralt, S.; Hassoun, H.
Article Title: Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: Incidence and prognostic significance
Journal Title: Leukemia
Volume: 27
Issue: 12
ISSN: 0887-6924
Publisher: Nature Publishing Group  
Date Published: 2013-12-01
Start Page: 2422
End Page: 2424
Language: English
DOI: 10.1038/leu.2013.126
PROVIDER: scopus
PUBMED: 23608883
DOI/URL:
Notes: Export Date: 2 January 2014 -- CODEN: LEUKE -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sergio Andres Giralt
    1068 Giralt
  2. Dmitriy Zamarin
    202 Zamarin
  3. Hani Hassoun
    338 Hassoun
  4. Heather Jolie Landau
    435 Landau
  5. Nikoletta Lendvai
    106 Lendvai
  6. Maria Eugenia Arcila
    670 Arcila
  7. Alexander Meyer Lesokhin
    378 Lesokhin
  8. David Chung
    250 Chung
  9. Sean McCarthy Devlin
    615 Devlin
  10. Jonathan Ian Weltz
    4 Weltz